Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Lilly, Novo lock horns in India's obesity drug race - 2A Manual for SUVs with Less Noteworthy Gas Mileage
- 3UK clothing inflation climbs as Middle East turmoil threatens wider price rises
- 4Nitty gritty Manual for Picking Agreeable Tennis shoes
- 5Sentimental tree to shine at Arctic League annual broadcast
- Hamas delegation meets Egypt’s spy chief amid mutual ceasefire violation claims
- Instructions to Decide whether a Fender bender Legal counselor is Required for Your Particular Case
- Which Brilliant Home Gadget Can't You Reside Without?
- See the first close-up photos of the moon from NASA's Artemis II mission
- When is MLK Day? Plus, the dates of when other federal holidays land in 2026.
- When Would it be a good idea for you to Look for Help from a Criminal Legal counselor?
- RSF attack on Sudan’s South Kordofan kills at least 14, including children
- Real time features for Films and Programs
- Instructions to Expand Your Smash 1500's Presentation: Tips and Deceives
